Introducing Critical Accounting for Governance as a Tool in Exploring the Commercial Determinants of Health

Document Type : Viewpoint


1 Department of Management, University of St Andrews, St Andrews, UK

2 School of Social and Political Science, University of Edinburgh, Edinburgh, UK

3 MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, UK


Introduction and Context

Commercial determinants of health (CDoH) are defined by the WHO1 as comprising “private sector activities that affect people’s health positively or negatively”. They “arise in the context of the provision of goods or services for payment and include commercial activities, as well as the environment in which commerce takes place.” Emerging literature examines the various health effects of commercial actors, such as lobbying and policy influence, product marketing and consumption and through system-level effects.2 We offer here an additional tool for future research efforts. (Read more...)

  1. WHO. Commercial determinants of health factsheet. 2021. Accessed 7/12/21.
  2. Gilmore AB, Fabbri A, Baum F, et al. Defining and conceptualising the commercial determinants of health. The Lancet. 2023;401(10383):1194-1213.
  3. Elsevier. Critical Perspectives on Accounting - Aims and scope. 2022; Accessed 5/4/2022.
  4. Business for Health, Confederation of British Industry. Business Framework For Health: supporting businesses and employers in their role to enhance and level up the health of the nation2021.
  5. Marmot MG, Rose G, Shipley M, Hamilton PJ. Employment grade and coronary heart disease in British civil servants. Journal of Epidemiology and Community. 1978;32:244-249.
  6. Employment conditions Knowledge network (EMCONET). Employment Conditions And Health Inequalities: Final Report to the WHO CSDH. Geneva: WHO Commission on Social Determinants of Health;2007.
  7. McCartney G, Hearty W, Arnot J, Popham F, Cumbers A, McMaster R. Impact of Political Economy on Population Health: A Systematic Review of Reviews. Am J Public Health. 2019;109(6):e1-e12. doi:10.2105/AJPH.2019.305001
  8. Wang Y, Mechkova V, Andersson F. Does Democracy Enhance Health? New Empirical Evidence 1900-2012. Political Research Quarterly. 2019;72(3):554-569.
  9. Bollyky TJ, Templin T, Cohen M, Schoder D, Dieleman JL, Wigley S. The relationships between democratic experience, adult health, and cause-specific mortality in 170 countries between 1980 and 2016: an observational analysis. The Lancet. 2019;393(10181):1628-1640. doi:10.1016/s0140-6736(19)30235-1
  10. Collison D, Dey C, Hannah G, Stevenson L. Anglo‐American capitalism: the role and potential role of social accounting. Accounting, Auditing & Accountability Journal. 2010;23(8):956-981. doi:10.1108/09513571011092510
  11. OECD. G20/OECD principles of corporate governance. Paris: OECD Publishing; 2015.
  12. Sjoberg O. Corporate Governance and Earnings Inequality in the OECD Countries 1979-2000. European Sociological Review. 2008;25(5):519-533. doi:10.1093/esr/jcn069
  13. Hall PA, Soskice D. Varieties of Capitalism2001. doi:10.1093/0199247757.001.0001
  14. Collison D, Cross S, Ferguson J, Power D, Stevenson L. Shareholder Primacy In UK Corporate Law: an exploration of the rationale and evidence. London2011.
  15. Marmot MG, Allen J. From Science to Policy. In: Berkman L, Kawachi I, Glymour M, eds. Social Epidemiology. New York: Oxford University Press; 2014:562-576.
  16. Ottersen OP, Dasgupta J, Blouin C, et al. The political origins of health inequity: prospects for change. The Lancet. 2014;383(9917):630-667. doi:10.1016/s0140-6736(13)62407-1
  17. Ferguson J, Power D, Stevenson L, Collison D. Shareholder protection, income inequality and social health: A proposed research agenda. Accounting Forum. 2017;41(3):253-265. doi:10.1016/j.accfor.2016.12.005
  18. Contrafatto M, Ferguson J, Power D, Stevenson L, Collison D. Understanding power-related strategies and initiatives. Accounting, Auditing & Accountability Journal. 2019;33(3):559-587. doi:10.1108/aaaj-06-2018-3529
  19. Allen LN, Wigley S, Holmer H. Implementation of non-communicable disease policies from 2015 to 2020: a geopolitical analysis of 194 countries. The Lancet Global Health. 2021;9(11):e1528-e1538. doi:10.1016/s2214-109x(21)00359-4
  20. Vitols S, Kluge N. Introduction. In: Vitols S, Kluge N, eds. The Sustainable Company: a new approach to corporate governance. Brussels: ETUI aisbl; 2011.
  21. McQuaid R, Canduela J, Hollywood E, Bond S, Richard A, Blackledge G. Fit for Work? Health and Wellbeing of Employees in Employee Owned Businesses. Edinburgh Napier University: Employee Ownership Association;2012.
  22. Sikka P. Corporate governance: what about the workers? Accounting, Auditing & Accountability Journal. 2008;21(7):955-977. doi:10.1108/09513570810907438
  23. World Bank. GCI 4.0: 1.G Corporate Governance. In: Index WEFGC, ed: World Bank,; 2022.
  24. Armingeon K, Engler, K., Leeman, L., . Comparative Political Data Set 1960-2020. Department of Political Science UoZ, trans. Zurich2022.
  25. European Foundation for the Improvement of Living and Working Conditions. Industrial Relations Index. 2021. Accessed 10/1/2023, 2023.
  26. OECD. How do collective bargaining systems and workers’ voice arrangements compare across OEC and EU countries? In: OECD, ed. Innovation EUPfEaS, trans. OECD/AIAS ICTWSS database2022.
  27. World Values Survey Association. World Values Survey. 2022; Accessed 10/1/2023, 2022.
  28. European Values Survey. European Values Survey. 2023; Accessed 10/1/2023, 2023.
  29. Edelman Data & Intelligence. Edelman Trust Barometer 2022. In: Intelligence ED, ed. Edelman Trust Barometer2022.

Articles in Press, Accepted Manuscript
Available Online from 21 November 2023
  • Receive Date: 24 May 2023
  • Revise Date: 24 August 2023
  • Accept Date: 20 November 2023
  • First Publish Date: 21 November 2023